Goldman Sachs Group Inc Sangamo Therapeutics, Inc Transaction History

Goldman Sachs Group Inc

$780 Billion
Q3 2025

A detailed history of Goldman Sachs Group Inc transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 446,854 shares of SGMO stock, worth $196,615. This represents 0.0% of its overall portfolio holdings.

Number of Shares

446,854

Previous 182,264 145.17%

Holding current value

$196,615

Previous $98,000 205.1%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$0.44 - $0.7 $116,419 - $185,213	264,590 Added 145.17%	446,854 $299,000
Q2 2025 Aug 14, 2025	SELL	$0.43 - $0.81 $332,379 - $626,109	-772,975 Reduced 80.92%	182,264 $98,000
Q1 2025 May 09, 2025	SELL	$0.66 - $1.37 $430,102 - $892,787	-651,670 Reduced 40.55%	955,239 $630,000
Q4 2024 Feb 11, 2025	BUY	$0.78 - $2.87 $1.2 Million - $4.42 Million	1,538,428 Added 2246.5%	1,606,909 $1.64 Million
Q3 2024 Nov 14, 2024	SELL	$0.32 - $1.1 $404,791 - $1.39 Million	-1,264,973 Reduced 94.86%	68,481 $58,000

Q2 2024 Aug 13, 2024	BUY	$0.36 - $0.65 $252,297 - $455,536	700,826 Added 110.78%	1,333,454 $480,000
Q1 2024 May 15, 2024	BUY	$0.42 - $1.38 $156,636 - $514,661	372,943 Added 143.61%	632,628 $423,000
Q4 2023 Feb 13, 2024	SELL	$0.3 - $0.63 $409,571 - $860,099	-1,365,238 Reduced 84.02%	259,685 $140,000
Q3 2023 May 14, 2024	BUY	$0.58 - $1.47 $791,838 - $2.01 Million	1,365,238 Added 525.73%	1,624,923 $974,000
Q3 2023 Nov 14, 2023	BUY	$0.58 - $1.47 $292,726 - $741,910	504,701 Added 45.05%	1,624,923 $974,000
Q2 2023 May 14, 2024	BUY	$1.11 - $1.74 $51,154 - $80,187	46,085 Added 4.29%	1,120,222 $1.46 Million
Q2 2023 Aug 14, 2023	BUY	$1.11 - $1.74 $51,154 - $80,187	46,085 Added 4.29%	1,120,222 $1.46 Million
Q1 2023 May 14, 2024	SELL	$1.66 - $3.67 $287,246 - $635,056	-173,040 Reduced 13.87%	1,074,137 $1.89 Million
Q1 2023 May 11, 2023	SELL	$1.66 - $3.67 $287,246 - $635,056	-173,040 Reduced 13.87%	1,074,137 $1.89 Million
Q4 2022 May 14, 2024	BUY	$2.77 - $5.07 $147,062 - $269,171	53,091 Added 4.45%	1,247,177 $3.92 Million
Q4 2022 Feb 13, 2023	BUY	$2.77 - $5.07 $147,062 - $269,171	53,091 Added 4.45%	1,247,177 $3.92 Million
Q3 2022 May 14, 2024	SELL	$4.27 - $6.39 $1.09 Million - $1.63 Million	-254,573 Reduced 17.57%	1,194,086 $5.85 Million
Q3 2022 Nov 10, 2022	SELL	$4.27 - $6.39 $1.09 Million - $1.63 Million	-254,573 Reduced 17.57%	1,194,086 $5.85 Million
Q2 2022 May 14, 2024	BUY	$3.28 - $6.21 $3.9 Million - $7.38 Million	1,188,974 Added 457.85%	1,448,659 $6 Million
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.21 $934,052 - $1.77 Million	284,772 Added 24.47%	1,448,659 $6 Million
Q1 2022 May 16, 2022	SELL	$5.23 - $7.82 $277,237 - $414,530	-53,009 Reduced 4.36%	1,163,887 $6.76 Million
Q4 2021 Feb 14, 2022	SELL	$7.29 - $10.97 $3.12 Million - $4.69 Million	-427,428 Reduced 25.99%	1,216,896 $9.13 Million
Q3 2021 Nov 10, 2021	BUY	$9.01 - $12.01 $14.8 Million - $19.7 Million	1,644,324 New	1,644,324 $14.8 Million

Others Institutions Holding SGMO

# of Institutions

124

Shares Held

62.5M

Call Options Held

953K

Put Options Held

1.11M

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $68.9M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Sangamo Therapeutics, Inc Transaction History